BridgeMD
New treatment option for Concussion, Intermediate
Official title Magnesium and Riboflavin Treatment for Post-Concussion Headache
ClinicalTrials.gov ID: NCT06260072
What this study is testing
What is magnesium and riboflavin supplement?
magnesium and riboflavin supplement is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for concussion, intermediate.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Seen at University of Virginia Student Health and Wellness Center or Emergency Department for Initial Visit for Concussion;
- Less than 3 days have elapsed since their injury;
- Able to swallow capsules
You likely can't join if
- Concussion complicated by cranial bleed, skull fracture, additional severe injury;
- Kidney disfunction or failure;
- Significant gastro-intestinal dysfunction;
- Varsity Athlete;
- Two or more previous concussions;
- Women who are pregnant or breast feeding;
See the full eligibility criteria
- Seen at University of Virginia Student Health and Wellness Center or Emergency Department for Initial Visit for Concussion;
- Less than 3 days have elapsed since their injury;
- Able to swallow capsules
- Concussion complicated by cranial bleed, skull fracture, additional severe injury;
- Kidney disfunction or failure;
- Significant gastro-intestinal dysfunction;
- Varsity Athlete;
- Two or more previous concussions;
- Women who are pregnant or breast feeding;
- Taking tetracycline, fluoroquinolone, iron digoxin, chlorpromazine or penicillamine
The study team makes the final eligibility decision.
Where it's taking place
- Charlottesville, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Charlottesville, Virginia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.